Leaders in Pharmaceutical Business Intelligence (LPBI) Group

About: Demet Sag

Website

http://demetsag.wordpress.com

Details

www.linkedin.com/in/demetsag Dr. Sag has speciliazed in Molecular Genetics and Developmental Biology. Applied her strong scientific knowledge on translational research for diagnostics and targeted therapies with cutting edge technologies. She turns around failing projects to the completion by gathering resources, training others if necessary, and manage budgets to execute them on time correctly. Worked in public, private and federal working environments with stellar scientists. These interactions brought her an important perspective to solve obstacles wisely. She has experienced both in academic and industrial settings which is very unique. Warm persona with ironmade standards on work ethics, time management, work-life balance that will benefit any team. Specialties PRODUCT DEVELOPMENT: Gene Therapy, Antifungal Therapy, Biotechnology, Biosensors DISCOVERY: Embryonic Stem Cell, Translational Research, Genome Structure and Function, Epigenetics.

Posts by Demet Sag:

• November 3, 2015 Supportive Treatments: Hold the Mind Strong During Cancer

• October 20, 2015 Tannins and tannosomes “An apple a day keeps the doctor away.” Traditional American rhyme

• October 20, 2015 Pharmacogenomics visited for Anticoagulant Therapy

• October 20, 2015 Where Infection meets with Cancer: Kaposi’s sarcoma (KS) is the most common cancer in HIV-1-infected persons and is caused by one of only 7 human cancer viruses, i.e., human herpesvirus 8 (HHV-8).

• October 19, 2015 The Relation between Coagulation and Cancer affects Supportive Treatments

• October 15, 2015 In the name of Translation from a food born pathogen to a friendly vaccine: Listeria monocytogenes

• October 14, 2015 Renal (Kidney) Cancer: Connections in Metabolism at Krebs cycle and Histone Modulation

Older Posts »